A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage pancreatic cancer patients.
Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced stages when the disease has already spread, or metastasized. About half of ...
The Brighterside of News on MSN12h
Breakthrough mRNA vaccine reinvents pancreatic cancer treatmentLong before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...
February was heart months, and this is another column in a series about the major risk factors for heart attacks. According ...
A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...
News-Medical.Net on MSN15d
Targeted nanoparticles show promise in preventing pancreatic cancer spread to the liverPancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...
The mRNA vaccine works by targeting genetic mutations found in pancreatic cancer ... emphasizing the trial's small size. Dr. Suneel Kamath, a gastrointestinal oncologist at Cleveland Clinic ...
Medpage Today on MSN14h
Preventive Care Mandate at Risk? More AI Wins in Cancer; Risky Short-Term InsuranceThe American Medical Association and more than two dozen other health organizations joined in an amicus brief encouraging the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback